PHAS

PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

PHAS was delisted on the 2nd of November, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in PhaseBio Pharmaceuticals, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
–
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$9.69K
2
-$4K
3
-$1K
4
IIA
IPG Investment Advisors
California
-$864
Name Holding Trade Value Shares
Change 		Change in
Stake
DCM
1
DAFNA Capital Management
California
–
Acadian Asset Management
2
Acadian Asset Management
Massachusetts
–
HLA
3
Hamilton Lane Advisors
Pennsylvania
–
IIA
4
IPG Investment Advisors
California
–